Supporting Global Vigilance and Post Market Surveillance
VigiCarib network facilitates the submission of reports of suspected adverse drug reactions (ADRs), and reports of quality issues to international monitoring systems of the WHO Programme for International Drug Monitoring at Uppsala Monitoring Centre, and to the WHO Global Surveillance and Monitoring System. This assists Member States with limited human resources to contribute to global vigilance, and to receive information on international and regional trends in reporting.
Reports of suspected adverse drug reactions, and reports of suspect substandard / falsified / unregistered medicines may be submitted confidentially to VigiCarib using any of the following methods :
The VigiCarib Reporting form in Word;
The VigiCarib Online Form at: https://form.jotform.co/72934157245864; or
E-Reporting (for reports of suspected adverse drug reactions from St Vincent and the Grenadines): https://primaryreporting.who-umc.org/Reporting/Reporter?OrganizationID=VC